子宫内避孕器市场规模、份额、成长分析（按类型、按产品类型、按年龄、按最终用途行业、按地区）- 2025-2032 年行业预测

2023 年全球子宫内避孕器市场规模为 44 亿美元，预计将从 2024 年的 46 亿美元成长到 2032 年的 66 亿美元，预测期间（2025-2032 年）的复合年增长率为 4.6%。

由于人们对计划生育和生殖健康的认识不断提高，子宫内避孕器（IUD）市场在过去十年中经历了显着增长。子宫内避孕器因其有效性和低维护要求而受到认可，它能提供长期保护，且无需每天护理，因此对忙碌的女性很有吸引力。市场参与企业和卫生组织的意识不断提高、女性劳动参与率不断提高以及对非荷尔蒙避孕选择的需求不断增加，进一步促进了市场扩张。技术进步和非荷尔蒙子宫内避孕器的引入满足了女性寻求荷尔蒙避孕替代方法的需求。然而，文化禁忌和对子宫内避孕器安全性的误解、对其侵入性的认知以及服务不足地区的成本对子宫内避孕器的广泛采用构成了挑战。儘管存在这些障碍，子宫内避孕器市场仍在持续成长，尤其是在新兴经济体。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析
• 客户和购买标准分析

子宫内避孕器市场规模（按类型及复合年增长率）（2025-2032）

• 市场概览
• 荷尔蒙子宫内避孕器
• 铜子宫内避孕器

子宫内避孕器市场规模（依产品类型及复合年增长率）（2025-2032）

• 市场概览
• 曼月乐
• 斯凯拉
• 帕拉加德
• 以述
• 雷沃塞特
• 其他的

子宫内避孕器市场规模（依年龄组别划分）及复合年增长率（2025-2032）

• 市场概览
• 15-24岁
• 25-34岁
• 35-44岁
• 年龄 44 岁或以上

子宫内避孕器市场规模（依最终用途产业划分）及复合年增长率（2025-2032）

• 市场概览
• 医院
• 妇科诊所
• 社区医疗中心
• 其他的

子宫内避孕器市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Teva Pharmaceutical Industries Ltd.（Jerusalem）
• Bayer（Germany）
• EUROGINE（Spain）
• CooperSurgical Inc.（US）
• Pfizer Inc.（US）
• HLL Lifecare Limited（Thiruvananthapuram）
• OCON Medical Ltd.（Israel）
• Prosan International BV（Netherlands）
• Melbea Innovations（Hungary）
• Allergan, Merck & Co., Inc.（US）
• DKT International（US）
• Medisafe Distribution Inc.（Canada）
• Medicines360（US）
• Pregna International Limited（India）
• Egemen International（Turkey）

结论和建议

Global Intrauterine Contraceptive Devices Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.6 billion in 2024 to USD 6.6 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

The Intrauterine Contraceptive Devices (IUDs) market has seen substantial growth over the past decade, driven by heightened awareness of family planning and reproductive health. Recognized for their effectiveness and low maintenance needs, IUDs provide long-lasting protection without daily attention, appealing to busy women. Government initiatives and health organizations have amplified awareness, women's increased participation in the workforce, and a rising demand for hormone-free contraceptive options further bolster market expansion. Technological advancements and the introduction of non-hormonal IUDs cater to women seeking alternatives to hormonal methods. However, cultural taboos and misconceptions regarding IUD safety, alongside the perceived invasiveness of insertion and costs in underserved areas, pose challenges to wider adoption. Despite these hurdles, the IUD market continues to thrive, particularly in emerging economies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intrauterine Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intrauterine Contraceptive Devices Market Segments Analysis

The Global Intrauterine Contraceptive Devices Market is segmented by Type, Product Type, Age Group, End Use and region. Based on Type, the market is segmented into Hormonal Intrauterine Device and Copper Intrauterine Device. Based on Product Type, the market is segmented into Mirena, Skyla, Paragard, Essure, Levosert and Others. Based on Age Group, the market is segmented into 15-24 years, 25-34 years, 35-44 years and Above 44 years. Based on End Use, the market is segmented into Hospitals, Gynecology Clinics, Community Health Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intrauterine Contraceptive Devices Market

The global market for intrauterine contraceptive devices (IUDs) is significantly driven by the increasing adoption of long-acting reversible contraceptives (LARCs). Women are gravitating towards methods that not only provide high effectiveness and low maintenance but also offer long-term pregnancy prevention, with IUDs boasting over 99% effectiveness and lasting 3 to 10 years depending on the type. This makes them a favorable alternative to daily or short-term contraceptive methods. Moreover, the advocacy of healthcare professionals, who often recommend LARCs as a primary contraceptive choice, further boosts IUD usage. Enhanced awareness campaigns highlight the convenience and reliability of these options, increasing their acceptance across diverse demographics and regions.

Restraints in the Global Intrauterine Contraceptive Devices Market

Despite the medical benefits of intrauterine contraceptive devices (IUDs), their adoption is often hindered by cultural and social barriers in many regions globally, including Asia, Africa, and the Middle East. Misconceptions surrounding IUD safety, potential fertility impacts, and procedural discomfort continue to prevail. Additionally, discussions about contraception are frequently stigmatized, leaving women with limited access to effective birth control options like IUDs. Fears about severe side effects and religious objections further inhibit market penetration. To improve awareness and acceptance of IUDs among hesitant groups, targeted educational and community outreach campaigns are essential to dispel myths and promote informed choices.

Market Trends of the Global Intrauterine Contraceptive Devices Market

The Global Intrauterine Contraceptive Devices (IUDs) market is experiencing a significant shift towards non-hormonal contraceptive options, driven by growing consumer preference for hormone-free solutions. As awareness of potential side effects associated with hormonal birth control rises, more women are gravitating toward devices like the Copper IUD, which offer long-term efficacy without altering hormonal balance. This trend is particularly pronounced in health-conscious populations seeking non-invasive, reliable alternatives. Consequently, manufacturers are adapting by innovating designs and enhancing comfort in non-hormonal IUDs, positioning these products competitively within the global market landscape and catering to the increasing demand for safer contraceptive choices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis
• Customer & Buying Criteria Analysis

Global Intrauterine Contraceptive Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Hormonal Intrauterine Device
• Copper Intrauterine Device

Global Intrauterine Contraceptive Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Mirena
• Skyla
• Paragard
• Essure
• Levosert
• Others

Global Intrauterine Contraceptive Devices Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• 15-24 years
• 25-34 years
• 35-44 years
• Above 44 years

Global Intrauterine Contraceptive Devices Market Size by End Use Industry & CAGR (2025-2032)

• Market Overview
• Hospitals
• Gynecology Clinics
• Community Health Care Centers
• Others

Global Intrauterine Contraceptive Devices Market Size & CAGR (2025-2032)

• North America (Type, Product Type, Age Group, End Use Industry)
  • US
  • Canada
• Europe (Type, Product Type, Age Group, End Use Industry)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product Type, Age Group, End Use Industry)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product Type, Age Group, End Use Industry)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product Type, Age Group, End Use Industry)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Teva Pharmaceutical Industries Ltd. (Jerusalem)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROGINE (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited (Thiruvananthapuram)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OCON Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prosan International BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melbea Innovations (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan, Merck & Co., Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicines360 (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Egemen International (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations